09 Set Comunicazioni orali selezionate

Di seguito riportiamo l’elenco delle Comunicazioni Orali selezionate che saranno presentate a Roma. Tutti i poster inviati sono stati accettati per il Final Contest, la prossima settimana ne pubblicheremo l’elenco dettagliato.

L’ordine di presentazione delle singole relazioni a cura degli Autori sarà quanto prima comunicata con la pubblicazione del programma finale dell’evento previsto per le giornate del 29 e 30 settembre a Roma.

•  ANTONELLI Alberto |Firenze • First detection of a multiresistance transposon of original structure harbouring cfr gene and a novel putative efflux pump in a linezolid-resistant MRSA

• BAI Francesca | Milano • Factors associated with anal/cervical HPV infection and dysplasia in a cohort of HIV-infected male and female patients

• BARTOLETTI Michele | Bologna • Bloodstream infection in cirrhotic patients: a prospective multicenter study (Bichrome)

• BERTOLDI Alessia | Bologna • Longitudinal evaluation of reservoir size decay in naïve HIV patients starting ART

• BOGLIONE Lucio | Torino •  Treatment with daclatasvir and sofosbuvir for 24 weeks without ribavirin in cirrhotic patients who failed first-generation protease inhibitors

• BOZZI Giorgio | Milano • No Evidence of Ongoing Replication in Tissue Compartments During Combination Antiretroviral Therapy

• CANNIZZO Stefania E. | Milano • Role of microbial translocation in HIV infected patients during suppressive Antiretroviral Therapy (cART) and causal relationship with HIV-driven bone impairment

• CENTO Valeria | Roma • High efficacy of HCV resistance-guided retreatment strategies after protease inhibitors failure in real-life settings

• CORCIONE Silvia| Torino • Antimicrobial Stewardship in a Long Term Acute Care Hospital Using Offsite Electronic Medical Record Audit

• D’ABRAMO Alessandra | Roma • Higher Levels of Osteoprotegerin and Immune Activation/Immunosenescence Markers Are Correlated with Concomitant Bone and Endovascular Damage in HIV-Suppressed Patients

• DE PASCALIS Stefania | Napoli • ITPase activity modulates the severity of anemia in patients with hcv-related cirrhosis treated with ribavirin-containing IFN-free regimens

• DE ROSA Annalisa | Roma • Extensively drug resistant Pseudomonas aeruginosa: a study on carbapenem resistance mechanisms

• DEL PUENTE Filippo | Genova  • Bone status evaluation by QUS in patients perinatally infected with HIV-1. A longitudinal study from childhood to early adult age

• DI CRISTO Valentina | Milano • Factors involved in continuance of atazanavir-based regimens : results from a cohort of HIV1-positive patients

• DI GENNARO Francesco | Bari  • The sound of TB: role of lung ultrasound in the diagnosis and follow-up of pulmonary tuberculosis in resource limited settings

• FOCA’ Emanuele | Brescia  •  Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV co-infected patients with detectable HCV RNA. A MASTER Cohort study

• GIACOBBE Daniele Roberto | Genova  • Lower sensitivity of serum (1,3)-beta-D-glucan for the diagnosis of candidemia due to Candida parapsilosis

• GIROMETTI Nicolò | Bologna  • Outcomes of acutely HIV-1 infected individuals following rapid antiretroviral therapy initiation.

• IANNETTA Marco | Roma  • Natalizumab affects T-cell phenotype in multiple sclerosis: implications for JCV reactivation

• LAGI Filippo | Firenze  • Proposal for a New Score-Based Approach To Improve Efficiency of Diagnostic Laboratory Workflow for Acute Bacterial Meningitis in Adults

• MACERA Margherita | Napoli  • CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection

• MALAGNINO Vincenzo | Roma • Emerging genotype E of Hepatitis B Virus in Young African migrants in Rome: new clinical and virological settings

• MAZZANTI Sara | Ancona  • Epidemiologia, caratteristiche cliniche e mortalità della candidemia nell’età avanzata

• MAZZITELLI Maria | Catanzaro  •  Studio CARDIAC: (CARdiac DIseases in Antiviral therapy for HCV). Valutazione della funzionalità cardiaca in pazienti con infezione da HCV in trattamento con nuovi DAA

• MENOZZI Marianna | Modena  • CD4/CD8 ratio matters to age related health outcomes in HIV infected patients with comorbidities, frailty and disability.

• MERLINI Esther | Milano  •  Association Between Mucosal-Associated Invariant T (MAIT) Cells and Gut Microbiome: Friend or Foe in Chronic Viral Infections?

• MUSUMECI Giuseppina | Bologna  • M48U1 and Tenofovir combination synergistically inhibits HIV-1 infection in activated PBMCs and human cervicovaginal histocultures

• ONORATO Lorenzo | Napoli  • Occult HBV infection in HCC and cirrhotic tissue of HBsAg-negative patients: a virological and clinical study

• PASCALE  Renato | Bologna  •  Tigecycline, an ecological choice? Retrospective cohort study of colonization or infection risk with Carbapenems-Resistant Klebsiella pneumoniae or Clostridium difficile following antibiotic treatment of intra-abdominal infection

• RINALDI Francesca | Pavia  • Medical treatment versus “Watch and Wait” in the clinical management of CE3b echinococcal cysts of the liver

• RONZI Paola | Milano  • Attività e tossicità in vitro dei composti peptidomimetici biciclici come inibitori della proteasi di HIV-1

• RUGGIERO Alessandra | Liverpool  • During stably suppressive antiretroviral therapy integrated HIV-1 DNA load in peripheral blood is associated with the frequency of CD8 cells expressing HLA-DR/DP/DQ

• SALADINI Francesco | Siena • Preliminary evaluation of antiviral activity of candidate HIV inhibitors targeting human DDX3 protein

• SATTA Giovanni | Londra  • Genetic variation in Mycobacterium tuberculosis isolates from a London outbreak associated with isoniazid resistance

• STRAZZULLA Alessio | Catanzaro  •  Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection?

• SVICHER Valentina | Roma  • Identification and Characterization of Specific Genetic Elements in HBV Surface Glycoprotein correlated with Hepatocellular Carcinoma: An In Vivo and In Vitro Analysis

• TURRINI Filippo | Milano  • The HIV-1 Transcriptional Repressor TRIM22 Is a Novel Determinant of Proviral Latency and Disease Progression

• VELOCI Sara | Firenze  • HBV in gravidanza: analisi di una popolazione di 213 gestanti e valutazione dell’outcome dei nati da donne con elevata viremia presso l’Azienda Ospedaliero Universitaria Careggi, Firenze.

• VENANZI-RULLO Emmanuele | Messina  •  Amfotericina in aerosol per il trattamento dell’aspergillosi polmonare invasiva, uno studio di coorte retrospettivo osservazionale”

• ZAMMARCHI Lorenzo | Firenze  •  A scoping review of cost-effectiveness of screening and treatment for latent tubercolosis infection in migrants from high-incidence countries